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Abstract
Abnormal pain processing in the central nervous system may be related to abdominal pain in 
patients with Crohn's disease (CD). The purpose of this study was to investigate changes in 
resting-state brain activity in CD patients in remission and its relationship with the presence of 
abdominal pain. Twenty-five CD patients with abdominal pain, 25 CD patients without abdominal 
pain, and 32 healthy subjects were scanned using a 3.0 T functional magnetic resonance imaging 
(fMRI) scanner. Regional homogeneity (ReHo) was used to assess resting-state brain activity. 
Daily pain scores were collected 1 week before fMRI scanning. We found that patients with 
abdominal pain exhibited lower ReHo values in the insula, middle cingulate cortex (MCC), and 
supplementary motor area, and higher ReHo values in the temporal pole. In contrast, patients 
without abdominal pain exhibited lower ReHo values in the hippocampal/parahippocampal cortex 
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and higher ReHo values in the dorsomedial prefrontal cortex (all P<0.05, corrected). The ReHo 
values of the insula and MCC were significantly negatively correlated with daily pain scores for 
patients with abdominal pain (r=−0.53, P=0.008, and r=−0.61, P=0.002, respectively). These 
findings suggest that resting-state brain activities are different between remissive CD patients with 
and without abdominal pain, and that abnormal activities in insula and MCC are closely related to 
the severity of abdominal pain.
Keywords
Functional magnetic resonance imaging; Neuroplasticity; Regional homogeneity; Pain; Crohn's 
disease
1. Introduction
Abdominal pain is one of the main complains of CD, which occurs throughout acute 
inflammation and even in clinical and/or endoscopic remission [9]. Treatment options for 
this particular symptom are limited due to its obscure mechanism [40]. The potential 
mechanisms include inflammation, visceral hypersensitivity, brain-gut axis dysfunction and 
psychological abnormalities, among which dysfunction of brain-gut interactions is 
considered to be vital [11, 32].
Resting-state functional magnetic resonance imaging (rs-fMRI) detects blood oxygenation 
level dependent (BOLD) signals, and can be used to explore spontaneous activities of 
neurons under a resting state. Regional homogeneity (ReHo) is a new analytical method that 
can be used to characterize the synchronization of fluctuations of BOLD signals among 
neighboring voxels within a single region. Based on the assumption that temporal patterns in 
spatially neighboring voxels within a functional region should share similarity, changes in 
ReHo values suggest possible synchronization and coordination abnormalities of 
spontaneous neuronal activities in corresponding brain region [45]. Therefore ReHo could 
be a valuable method complementary to brain structure measurement and could provide a 
better understanding of pathophysiological changes in brain function. Many recent studies of 
pain-related diseases, such as irritable bowel syndrome (IBS) [19, 28], migraine [44], and 
complex regional pain syndrome [10], have adopted rs-fMRI to detect pathophysiological 
changes in certain brain regions that are related to the recognition and processing of pain 
signals. In recent years, there has been growing interest in the use of MRI to detect the 
correlation between brain activities and inflammatory visceral pain in inflammatory bowel 
diseases (IBD) [1-3, 6, 20, 47]. Previous studies show alternations in gray matter (GM) 
structures including GM volumes and cortical thickness in multiple brain regions of CD 
patients, which in certain brain regions are correlated with disease duration [1, 6]. CD 
patients also have been found to exhibit altered habituation to stress and altered neural 
activity in the amygdala, hippocampus, insula, putamen, and cerebellar regions when 
performing stress-evoking tasks [2]. However, to date, there has been no study on resting-
state brain activity in CD patients. We believe that rs-fMRI based on ReHo analysis may 
provide a new insight into the neurophysiology of CD. Given the importance of abdominal 
pain in CD and the known association between chronic visceral pain and abnormal resting-
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state brain activities [31], it is necessary to understand whether abdominal pain affects 
resting-state brain activity in CD patients, and whether ReHo values differ between CD 
patients with and without abdominal pain.
We hypothesized that the resting-state brain activity in CD patients with abdominal pain is 
different from those without abdominal pain, and that brain regions with abnormal ReHo in 
patients with abdominal pain are involved in processing visceral pain signals. The aims of 
the study were (1) to compare ReHo values between CD patients with and without 
abdominal pain using rs-fMRI;(2) to examine a potential correlation between the ReHo 
values and daily pain scores in patients with abdominal pain.
2. Methods
The study protocol has been approved by the Ethics Committee of Yueyang Hospital of 
Integrative Traditional Chinese and Western Medicine affiliated with Shanghai University of 
Traditional Chinese Medicine.
2.1. Subjects
CD patients: A total of 50 CD patients were included via continuous, non-selective 
recruitment. There were 25 patients with abdominal pain and 25 without abdominal pain. All 
patients were recruited from the inflammatory bowel disease specialist outpatient clinic of 
Shanghai Institute of Acupuncture and Meridian affiliated with Shanghai University of 
Traditional Chinese Medicine and the Endoscopy Center of Zhongshan Hospital affiliated 
with Fudan University. All patients received systemic and gastrointestinal examinations (i.e., 
colonoscopy and pathology biopsy). Laboratory tests and colonoscopy were completed in 2 
weeks and 1 month before MRI scanning. C-reactive protein (CRP), erythrocyte 
sedimentation rate (ESR), platelet (PLT) levels and Crohn's disease endoscopic index of 
severity (CDEIS) scores were collected from all patients.
Inclusion criteria: (1) age 18–50 years old; (2) education ≥ 6 school years; (3) in remission 
for 12 months or longer; (4) the Crohn's disease activity index (CDAI) ≤150; and (5) 
CDEIS<3; (6) right-handed.
Exclusion criteria: (1) abnormal biological disease activity indices (C reactive protein >10 
mg/L; erythrocyte sedimentation rate >20 mm/h; platelets >300×109/L); (2) having received 
CD-related abdominal surgery; (3) use of corticosteroids, biologics, psychotropic drugs or 
opioids in the past 3 months; (4) pregnant or lactating women; (5) current or history of 
psychiatric and neurological diseases, head trauma, or loss of consciousness; (6) patients 
with claustrophobia; and (7) patients with metal implants.
In addition, the Pain CD group included CD patients who experienced pain in the 
periumbilical region, the right lower quadrant or the left lower quadrant in the past 12 
months, with the days of pain per week ≥3 days. The Non-pain CD group included CD 
patients who had not experienced abdominal pain in the past 12 months.
Healthy controls (HCs): A total of 32 right-handed HCs were included in this study. They 
were recruited with advertisements from Shanghai University of Traditional Chinese 
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Medicine. None of the subjects in the HC group were taking any medication, or had 
gastrointestinal or pain related diseases, or had positive performance in colonoscopic 
examination.
All participating subjects were assessed by an experienced gastroenterologist in the 
gastroenterology department of Zhongshan Hospital affiliated with Fudan University, and 
screened for any neurological and psychiatric disorder by an experienced psychiatrist from 
Shanghai Mental Health Center according to the structured psychiatric interview for 
Diagnostic and Statistical Manual of Mental Disorders (4th Edition; DSM-IV).
2.2. Outcome assessment
The abdominal pain of all patients was assessed using a 0–10 cm visual analogue scale 
(VAS), with 0 representing no pain and 10 representing excruciating pain. The week before 
the fMRI scan the patients completed a daily pain log, the average pain score was calculated 
as the sum of the daily pain scores divided by the number of the days with pain. The 
patient's disease condition was evaluated using CDAI [8]. The quality of life of the patients 
was evaluated using the inflammatory bowel disease questionnaire (IBDQ) [22]. The 
psychological conditions of all subjects were evaluated using the Hospital Anxiety and 
Depression Scale (HADS) [46].
2.3. MRI data acquisition
Functional MRI was performed using a 3.0 Tesla MR scanner (Siemens Medical, Erlangen, 
Germany) equipped with a 12-channel head coil. Functional images were acquired with a 
single-shot gradient–recalled echo planar imaging (EPI) sequence (TR/TE: 2,000 ms/30 ms, 
field of view (FOV): 240 mm×240 mm, matrix size: 64× 64, flip angle: 90°, in-plane 
resolution: 3.75 mm×3.75 mm and 32 sagittal slices). A set of high-resolution T1-weighted 
structural images was also collected (TR/TE: 2.3 s/2.98 ms, FOV: 256 mm×256 mm, matrix 
size: 256×256, flip angle: 9°, in-plane resolution: 1 mm × 1 mm, slice thickness: 1.0 mm 
with no gaps and 176 slices).
2.4. Imaging data preprocessing
The resting-state fMRI data were pre-processed using SPM8 software package (http://
www.fil.ion.ucl.ac.uk/spm/software/spm8). The first five images of each functional time 
series were discarded for the longitudinal magnetization to reach equilibrium. All slices of 
the remaining images were processed by slice-timing adjustment and realigned to the first 
volume. Then, the time series of images of each subject were motion-corrected, the head 
motion parameters were obtained by estimating six parameters capturing translation and 
angular rotation relative to the first volume. The given data set in which the translation or 
rotation parameters exceeded 1.5 mm or 1.5 degrees rotation was discarded. The realigned 
functional images were then spatially normalized to Montreal Neurologic Institute (MNI) 
space using the normalization parameters estimated by T1 structural image unified 
segmentation, re-sampled to 3 mm voxels. In order to conserve the fine-grained local pattern 
and to avoid artificial connections, smoothing was not applied to the normalized data. 
Several sources of spurious variance, including estimated motion parameters, linear drift, 
and average BOLD signals in ventricular and white matter regions, were removed from the 
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data through linear regression. After that, temporal bandpass filtering (0.01–0.08 Hz) was 
performed to reduce the effect of low-frequency drifts and high-frequency noise. All of these 
procedures were performed using DPARSF software (http://www.restfmri.net/forum/
DPARSF).
2.5. ReHo analysis
Individual ReHo maps were generated by calculating Kendall's coefficient of concordance 
(KCC) [45], used to measure the correlation of the time series of a given voxel with the time 
series of its 26 nearest neighbors, within a GM mask in a voxel-wise manner using REST 
software (http://restfmri.net/forum/index.php) [43]. When the center cube was on the edge of 
the GM mask, we only calculated ReHo for a voxel if all of the remaining nearest voxels 
were within the GM mask. For each participant, the KCC map was normalized by dividing 
KCC in each voxel by the mean KCC of the total GM again using the DPARSF software.
2.6. Statistical analysis
2.6.1. Behavioral data—Statistical analyses were performed using SPSS 16.0 (SPSS Inc., 
Chicago, IL, USA). The mean ± standard deviation was used for normally distributed 
continuous variables; the median, 25th and 75th percentiles were used for non-normal 
distributed continuous variables; and frequencies and proportions were used for categorical 
variables. A two independent samples t test /one way analysis of variance (ANOVA) was 
used for normally distributed continuous variables. Nonparametric tests (Kruskal- Wallis 
test) were used for between-group comparisons of non-normal distributed continuous 
variables. A Pearson's χ2 test or Fisher's exact test was used for between-group comparisons 
of categorical variables. All p values were two-sided and P<0.05 was considered statistically 
significant.
2.6.2. Imaging data—At the second level of analysis, to determine the differences in 
ReHo values among HCs and patients with or without abdominal pain, a one-way analysis 
of variance (ANOVA) was performed at each voxel to assess the main effect with a 
significance level of P<0.05 (false discovery rate corrected) and cluster size > 5. Age, 
gender, weight, anxiety and depression were deemed to be insignificant covariates.
Based on the brain regions showing differences in ReHo between the patients and the HCs 
based on the ANOVA results, regions of interest (ROIs) were selected from the sets of 
voxels within 6-mm spheres with the centers at the peaks of the clusters. To disclose a 
possible relationship between the ReHo values and the daily pain scores, a 2-step correlation 
analysis was conducted in patients with abdominal pain: (1) a Pearson's correlation analysis 
was applied to detect the relationship between the mean ReHo values in each ROI and the 
daily pain scores for CD patients with age, gender, weight, anxiety and depression as 
covariates. The significance level was set at P<0.05. Bonferroni test was used to correct for 
multiple comparisons. (2) whole-brain correlation analysis was applied to disclose potential 
correlations between brain regions and pain severity. The significance level was set at 
P<0.05. The false discovery rate was corrected with the cluster size exceeded 5.
Bao et al. Page 5
Pain. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Finally, all the ReHo-related maps were superimposed on a template provided by MRIcroN 
software (http://www.cabiatl.com/mricro/) for display, and the brain regions showing the 
differences were presented in MNI coordinates.
3. Results
3.1. Clinical characteristics
Among the 50 CD patients, 25 (50.0%) showed the symptom of abdominal pain. The 
average pain score ranged from 1 to 5.4, with mean and standard deviation values of 
3.02±1.52. The Pain CD group, the Non-pain group and the HC group did not differ 
significantly in demographic characteristics (i.e., gender, age, height, and weight). The Pain 
CD group and the Non-pain CD group did not differ significantly in disease course, 
Montreal classification, or concomitant medication. There was a significant difference in the 
HADS-A and HADS-D scores among the three groups (both P<0.01). The HADS-A and 
HADS-D scores of the patients in the Pain CD group were both significantly higher than that 
of HCs (both P<0.01), and the HADS-A scores of the patients in the Non-pain CD group 
were significantly higher than those of HCs (P<0.05). The HADS-D scores of the patients in 
the Pain CD group were significantly higher than those of the patients in the Non-pain CD 
group (P<0.05).
The pain group patients yielded higher CDAI scores and lower IBDQ scores than the non-
pain group patients (both P<0.001). The CRP levels in the pain group were also higher than 
the non-pain group (P<0.01), while the PLT and ESR levels between the two groups were 
not significantly different. There was no significant difference between the two CD groups 
in the CDEIS scores (Table 1). The CDAI scores of all patients were correlated with CDEIS 
scores (r=0.356, P<0.05), CRP levels (r=0.423, P<0.01), ESR levels (r=0.491, P<0.001) and 
PLT levels (r=0.340, P<0.05).
3.2. ReHo value differences among the three groups
A one-way ANOVA including the Pain CD group, the Non-pain CD group and the HC group 
revealed that the ReHo values differed significantly among the three groups (P<0.05, 
corrected) within six brain regions including: the left insula, the supplementary motor area 
(SMA), the midcingulate cortex (MCC), the hippocampus (HIPP)/paraHIPP, the temporal 
pole, and the right dorsomedial prefrontal cortex (dmPFC; Table 2; Figure 1A).
ReHo values extracted from the above six brain regions were subjected to post-hoc analysis. 
The results showed that the ReHo values of the insula, SMA and MCC in the patients from 
the Pain CD group were significantly lower compared to the Non-pain CD group and the HC 
group, whereas the ReHo values of the temporal pole (TP) in patients from the Pain CD 
group were significantly higher compared to the Non-pain CD group and the HC group 
(P<0.05, corrected). The ReHo values for HIPP/paraHIPP in patients from the Non-pain CD 
group were significantly lower compared to the Pain CD group and the HC group, whereas 
the ReHo values of dmPFC in patients from the Non-pain CD group were significantly 
higher compared to the Pain CD group and the HC group (all P<0.05, corrected; Figure 1B).
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The above results revealed that, among the three groups, CD patients with abdominal pain 
showed the lowest ReHo values in the insula, MCC and SMA, and the highest ReHo values 
in the TP, whereas CD patients without abdominal pain showed the lowest ReHo values in 
the HIPP/paraHIPP, and the highest ReHo values in the dmPFC.
3.3. Correlation between ReHo values and daily pain scores
The ReHo values in two brain regions of CD patients with abdominal pain from the group 
comparison were found to correlate with daily pain scores. The ReHo values in the insula 
and MCC of CD patients with abdominal pain were significantly negatively correlated with 
their daily pain scores (r=−0.53, P=0.008; r=−0.61, P=0.002; Figure 1C). The ReHo values 
in the HIPP and dmPFC of CD patients with abdominal pain were not significantly 
correlated with their daily pain scores (r=−0.33, P=0.138; r=0.37, P=0.096).
For the whole-brain analysis, the daily pain scores negatively correlated with the ReHo 
values of the left insula, MCC, right dorsolateral prefrontal cortex (dlPFC), bilateral 
thalamus, and periaqueductal gray (PAG), and positively correlated with the right 
orbitofrontal cortex (OFC) (Table 3, Figure 2).
4. Discussion
In this study, we show, for the first time, differences in the spontaneous BOLD signals in 
several brain areas among HCs and CD patients with and without abdominal pain. In CD 
patients with abdominal pain, there were substantial decreases of ReHo values in the insula, 
MCC and SMA, and increases of ReHo values in the TP. The reductions of the ReHo values 
in the insula and MCC in these patients were negatively correlated with the daily pain score. 
In CD patients without abdominal pain, there were substantial decreases of ReHo values in 
the HIPP/paraHIPP and an increase of ReHo values in the dmPFC. These results suggest a 
different reorganization of resting-state brain activities between CD patients in remission 
with and without abdominal pain. This may indicate an association between visceral pain 
and changes in brain activity in IBD patients.
The ReHo values of the insula, MCC, SMA and TP in CD patients with abdominal pain 
showed abnormal changes. Our previous study also revealed that the GM volumes in these 
brain regions of CD patients were significantly lower comparing to that of HCs [8]. Agostini 
et al. [1] reported GM volume decreases in the anterior MCC and part of the dorsolateral 
PFC of CD patients. Zikou et al. found decreased GM volumes in the right SMA, in the 
bilateral inferior temporal gyrus and some other brain regions in IBD patients [47]. Taken 
together, these results suggested abnormalities in both morphology and resting state 
functional activities of these brain areas in CD patients. Similar changes were also 
discovered in many other diseases with visceral pain, such as IBS [19, 30], functional 
dyspepsia [28], painful bladder syndrome/interstitial cystitis [24] and chronic pancreatitis 
[19]. These brain regions are important components of pain networks. The insula is 
responsible for the sensation of the body and internal organs, the control of visceral 
movement and autonomic nerves, and especially critical for pain perception. Functionally, 
the MCC, hypothalamus and PAG form a descending pain modulatory system, through 
which some supraspinal areas can directly or indirectly regulate the processing of 
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nociceptive stimuli on the dorsal horn of the spinal cord. MCC dysfunction may indicate 
damages to the endogenous pain suppressing system [17]. The insula and MCC dysfunctions 
suppress the reaction of the cingulated gyrus-PAG/brainstem descending inhibitory system 
and the receptive system in the anterior insula to nociceptive stimuli, thereby inhibiting the 
normal analgesic effect of the body [15]. The SMA is also part of a cortical network 
involved in the translation of painful cognition. The role of the TP in pain processing is not 
fully understood, but it may be related to imparting affective tone to short-term memories. In 
the present study, we observed higher HADS-D scores in CD patients with abdominal pain, 
suggesting that abdominal pain may aggravate CD patient's depression symptoms. The 
increase in TP ReHo values in CD patients with abdominal pain suggests increased 
synchronization of neuronal activities in this region, possibly because of compensatory 
cortical reorganization in this region.
Abnormal changes in the brain structure and function in patients with chronic visceral pain 
may be associated with chronic nociceptive stimulation and subsequent reorganization and 
plasticity of the brain. In CD patients, ascending intestinal inflammation/pain signals are 
transmitted through the brain–gut axis to cortical and subcortical areas. Through vagal 
afferent nerve fibers and spinal gastrointestinal afferent fibers, inflammatory signals are 
transmitted by cytokines and progressively coded in different levels of the CNS and finally 
projected to related cortical and subcortical regions. Intestinal inflammation signals can 
induce apoptosis of stellate cells and oligodendrocytes [12, 34]. Inflammatory mediators can 
also change the excitability of the CNS by activating microglia, macrophages and 
endothelial cells [13, 36-37]. In acute inflammation, systemic inflammatory stimulation 
increases the levels of proinflammatory and chemoattractant factors in the brain, and brain 
microglial cells play an important role in communicating between brain and systemic 
immune system [38, 42]. Cytokines can be synthesized locally in the brain, and periphery 
inflammatory cytokines can also reach the brain through active transportation and 
periventricular organs [25, 36].
The disease activity indices (CDAI scores and CRP levels) of CD patients with abdominal 
pain were significantly higher than those without abdominal pain, and the health-related 
quality of life was significantly lower, suggesting that abdominal pain severely affects 
disease activity and quality of life. In CD patients, abdominal pain during remission is 
chronic, involving a variety of factors, and is often difficult to accurately quantify and 
control. The one-week daily pain score log that we used in the current study is considered a 
rather robust method for assessing the severity of chronic pain [16, 23] and has been applied 
in a number of studies on chronic pain including abdominal pain in CD patients [4, 39]. 
Because abdominal pain in CD patients is commonly the most prominent symptom when 
they are seeking medical help and the patterns of pain remain relatively stable in most 
patients, the pain score log we used may provide an estimate of pain intensity in these 
patients that is similar to that experienced during prior time periods. The ReHo values of the 
insula and MCC were negatively correlated with the daily pain scores in these patients. 
Reduced ReHo values in the insula and MCC in patients with high abdominal pain scores 
would suggest reduced synchronization and coordination of neural activities in these brain 
regions. This negative correlation is opposite to the observation that in patients with chronic 
pancreatitis, the thicknesses of these two brain areas were positively correlated with daily 
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pain scores [17]. The whole-brain analysis further verifies this negative correlation, and 
improves the reliability of the results. A number pain related brain regions were found in this 
study. Interestingly, the daily pain scores were negatively correlated with decreased ReHo 
value of dlPFC, and simultaneously positively correlated with increased ReHo value of 
OFC, which parallel to the results from cyclic menstrual pain patients [41]. The dlPFC is a 
region important for top-down pain control, and has been implicated in disinhibition of 
orbitofrontal networks which may lead to enhanced negative affect [5, 29]. Furthermore, in 
the present study the ReHo values of the thalamus and PAG were negatively correlated with 
pain scores. This may be due to sustained abnormal nociceptive input to the brain, rather 
than with CD pain-specific pathology, because the ReHo values in these regions were not 
significantly different from patients with abdominal pain or HCs, and these regions are 
involved in other types of pain conditions [14]. These findings suggest that the dysfunction 
of dlPFC, OFC, thalamus and PAG may not be central to the pathophysiology of CD pain, 
but instead either they are adaptations to increased nociceptive input or they represent a 
preexisting vulnerability to experiencing greater pain [7].
Among the three groups, we found that CD patients without abdominal pain showed the 
lowest ReHo value of HIPP/paraHIPP and the highest ReHo value of dmPFC. In previous 
studies, abnormal BOLD signals in IBD patients relative to controls have been found in 
HIPP and mPFC [25, 30]. The HIPP/paraHIPP is associated with limbic and non-limbic 
systems. It regulates immune response through the hypothalamic–pituitary–adrenal (HPA) 
pathway and neurohormonal pathways, and plays an important role in neuroimmune 
regulation [26]. Studies have shown that experimental colitis/intestinal dysbiosis were 
associated with aberrant expression of brain-derived neurotrophic factor or its mRNA in the 
HIPP and abnormal development of anxiety-like behavior [18, 35]. Another study showed 
increased TNF-α levels in the HIPP and enhanced excitability of the CNS in rats with 
experimental colitis [4]. The HIPP may also interact with the vagus nerve, which plays a role 
in neural modulation of intestinal inflammation by releasing acetylcholine to regulate 
immune cells in the intestinal wall. Although studies of the role of the dmPFC in 
neuroimmune regulation are rare, it has been reported that the HIPP/paraHIPP is closely 
connected to the PFC, which forms the hippocampal-prefrontal cortical circuit [27]. The 
decrease of ReHo values in the HIPP/paraHIPP may cause excessive compensation of the 
cortical functional reorganization in the PFC, leading to increased ReHo values in the PFC 
in CD patients. Since the mPFC is known to be involved in regulating chronic pain [21, 33], 
the increased ReHo value in patients without abdominal pain may suggest enhanced 
compensation of the mPFC.
Beside these findings, the present study has certain drawbacks. Since it is a cross-sectional 
study, we could not determine whether the abnormal ReHo changes in CD patients occurred 
before the disease onset or subsequent to the disease. Additionally, neurotransmitter 
modulation and receptor binding in the related brain areas and their correlations with the 
resting-state brain activity could be measured in future studies.
In conclusion, we show different changes in ReHo values between remissive CD patients 
with and without abdominal pain. The decreased ReHo values of the insula and the MCC 
and their correlation with pain severity in CD patients with pain suggests the involvement of 
Bao et al. Page 9
Pain. Author manuscript; available in PMC 2017 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
these brain regions in the processing of visceral pain. These findings may help us to better 
understand the pathophysiology of visceral pain in CD patients and provide an insight to 
facilitate the development of new therapies in the future.
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Fig. 1. 
Significant differences in ReHo values among the pain CD, non-pain CD, and HC groups 
with age, gender, weight, anxiety and depression as covariates. (A) The main effect analysis 
revealed significant differences in ReHo values of the insula, hippocampal/parahippocampal 
cortex (HIPP/paraHIPP), dorsomedial prefrontal cortex (dmPFC), middle cingulate cortex 
(MCC), supplementary motor area (SMA) and temporal pole (TP) among the three groups. 
(B) The post-hoc analysis showed that the ReHo values of the insula, MCC and SMA in the 
pain CD group were lower and the TP was higher than the ReHo values of the other two 
groups. The ReHo values of the HIPP/paraHIPP in the non-pain group were lower and those 
of the dmPFC were higher than the ReHo values of the other two groups. (C) The ReHo 
values of the insula and MCC in the pain CD group were negatively correlated with the 
abdominal pain scores. L, left; r, correlation coefficient; VAS, visual analogue scale; 
*P<0.05, **P<0.01.
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Fig. 2. 
Brain regions with significant correlation between the ReHo values and daily pain scores in 
CD patients with abdominal pain using whole-brain correlation analysis. The daily pain 
scores correlated negatively with the left insula and MCC, right dorsolateral prefrontal 
cortex (dlPFC), bilateral thalamus, and periaqueductal gray (PAG), and positively with the 
right orbitofrontal cortex (OFC).
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Table 1
Demographic and clinical characteristics among pain CD group, non-pain CD group and healthy controls
Pain Group (n=25) Non-pain Group (n=25) HC (n=32) P value
Gender (male/female) 16/9 19/6 21/11 0.605
Age (y) 31.72±8.05 29.24±6.85 30.19±5.85 0.440
Height (cm) 169.72±8.06 170.72±6.08 169.38±7.55 0.781
Weight (kg) 56.28±9.43 57.50±9.54 58.97±6.46 0.488
HAD-A 6.48±3.51** 5.20±2.69* 3.31±1.99 0.000
HAD-D 5.68±3.74** 3.64±2.93# 2.97±1.71 0.014
Duration of illness (y) 6.74±4.40 5.64±3.80 — 0.489
CDAI 97.56±34.93 43.94±31.23### — 0.000
IBDQ 161.24±27.84 188.56±18.70### — 0.000
CRP 5.74±2.28 2.99±2.75## — 0.001
ESR 12.75±4.80 10.01±5.31 — 0.062
PLT 226.76±37.24 210.68±49.90 — 0.203
CDEIS 1.25±0.80 0.90±0.51 — 0.078
Montreal classification
Age at diagnosis A1 0 4 — 0.018
A2 21 21 —
A3 4 0 —
Location L1 3 7 — 0.344
L2 6 4 —
L3 16 14 —
L4 0 0 —
Behavior B1 8 8 — 0.556
B2 1 2 —
B3 7 7 —
B1P 1 4 —
B2P 1 0 —
B3P 7 4 —
Concomitant medication 17 16 — 1.000
5-aminosalicylate 11 11 —
azathioprine 3 4 —
5-aminosalicylate & azathioprine 3 1 —
Compare with HC group
Compare with pain group
CD, Crohn's disease; CDAI, Crohn's Disease Activity Index; HADS-A, Hospital Anxiety and Depression Scale anxiety score; HADS-D, Hospital 
Anxiety and Depression Scale depression score; HCs, healthy controls; IBDQ, Inflammatory Bowel Disease Questionnaire. Values are presented as 
mean ± standard deviation.
*for P<0.05
**for P<0.01
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#for P<0.05
##for P<0.01
###for P<0.001.
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Table 2
Brain regions with significant differences in ReHo values among the pain CD, non-pain CD, and HC groups
Regions Hem BA
MNI
F value Voxels
X Y Z
Insula L 48 −36 −30 17 10.71 14
MCC L 23 −2 −18 49 8.01 20
SMA L 6 −6 15 63 9.27 32
TP L 38 −48 24 −21 8.89 11
paraHIPP/HIPP L 30 −19 −31 −12 8.64 13
dmPFC R 8 6 32 45 13.51 12
The results employed age, gender, weight, anxiety and depression as covariates. The statistical threshold was set at P<0.05 (false discovery rate 
corrected) and cluster size > 5. CD, Crohn's disease; dmPFC, dorsomedial prefrontal cortex; HC, healthy control; HIPP/paraHIPP, hippocampal/
parahippocampal cortex; MCC, middle cingulate cortex; SMA, supplementary motor area; TP, temporal pole.
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Table 3
Whole-brain correlation analysis between the ReHo values and daily pain scores in CD patients with 
abdominal pain.
Regions Hem BA
MNI
T Value Voxels
X Y Z
Negative correlation
Insula L 13 −42 −12 3 −3.61 9
MCC L 24 −3 −9 42 −3.75 14
dlPFC R 9 33 24 51 −3.91 8
Thalamus L / −6 −21 3 −4.05 11
R / 6 −18 3 −3.71 15
PAG / / 3 −28 −9 −4.01 16
Positive correlation
OFC R 11 24 51 −15 4.67 18
The results employed age, gender, weight, anxiety and depression as covariates. The statistical threshold was set at P<0.05 (false discovery rate 
corrected) and cluster size > 5. BA, Brodmann area; dlPFC, dorsolateral prefrontal cortex; Hem, hemisphere; MCC, middle cingulated cortex; 
OFC, orbitofrontal cortex.
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